Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 15,668 | 10,296 | 0 | 5,519 | 4,166 |
| Operating Income | -15,668 | -10,296 | N/A | -5,519 | -4,166 |
| Other Income | 565 | 351 | 0 | 320 | 222 |
| Pre-tax Income | -15,103 | -9,945 | 0 | -5,199 | -3,944 |
| Net Income Continuous | -15,103 | -9,945 | N/A | -5,199 | -3,944 |
| Net Income | $-15,103 | $-9,945 | $N/A | $-5,199 | $-3,944 |
| EPS Basic Total Ops | -0.58 | -1.73 | N/A | -0.99 | -0.19 |
| EPS Basic Continuous Ops | -0.58 | -1.73 | N/A | -0.99 | -0.19 |
| EPS Diluted Total Ops | -0.58 | -1.73 | N/A | -0.99 | -0.19 |
| EPS Diluted Continuous Ops | -0.58 | -1.73 | N/A | -0.99 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.58 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-15,612 | $-10,259 | $N/A | $-5,504 | $-4,166 |